-+ 0.00%
-+ 0.00%
-+ 0.00%

Stifel Reinstates Buy on Cullinan Therapeutics, Announces $22 Price Target

Benzinga·06/11/2025 15:48:17
Listen to the news
Stifel analyst Alex Thompson reinstates Cullinan Therapeutics (NASDAQ:CGEM) with a Buy and announces $22 price target.